We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Researchers to Benefit from New Inverted Microscopes

By LabMedica International staff writers
Posted on 09 Nov 2016
A new inverted microscope platform with enhanced optical characteristics and extended water immersion capability is now available for biotech and other life science researchers.

The highly regarded microscope manufacturer ZEISS (Jena, Germany) has introduced the Axio Observer line of inverted microscopes for life science research. More...
The Axio Observer family comprises three stable and modular microscope stands for flexible and efficient imaging.

Axio Observer combines the proven quality of ZEISS optics with new automation features, allowing researchers to perform demanding multimodal imaging of living and fixed specimens. Among these features is Autocorr, a technology that allows adaptation of immersion objectives to varying sample carriers and imaging conditions.

The new Autoimmersion option that builds up and maintains stable water immersion without traditional problems such as evaporation or air bubbles is compatible with multiple water immersion objectives in the nosepiece. It uses a powerful piezo-electric pump to bring water from a small tank to a nozzle in the center of the objective turret. With a single click just the right amount of water is applied to the active immersion objective. This provides better contrast and resolution, more efficient light collection, and increased sensitivity.
Definite Focus.2 is a novel hardware focus feature that automatically compensates for focus drift and enables long-term time-lapse imaging and demanding multi-position experiments. Axio Observer can be combined with the new multicolor LED light source Colibri 7 that delivers up to seven excitation wavelengths. This light source, in combination with new Virtual Filter technology, enables researchers to perform ultrafast fluorescence imaging with high spectral flexibility.

The Axio Observer platform is controlled by ZEN imaging software. The current release 2.3 integrates all new features seamlessly and offers convenient experiment setup with dedicated wizards, large-data acquisition, and data processing in two and three-dimensions, including a powerful graphics card-enabled three-dimensional deconvolution. Data can easily be exported to a multitude of file formats and third-party software.

Related Links:
ZEISS


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.